English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 22 Help

Selected(0)Clear Items/Page:    Sort:
APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024 Journal article
Lau, George, Obi, Shuntaro, Zhou, Jian, Tateishi, Ryosuke, Qin, Shukui, Zhao, Haitao, Otsuka, Motoyuki, Ogasawara, Sadahisa, George, Jacob, Chow, Pierce K.H., Cai, Jianqiang, Shiina, Shuichiro, Kato, Naoya, Yokosuka, Osamu, Oura, Kyoko, Yau, Thomas, Chan, Stephen L., Kuang, Ming, Ueno, Yoshiyuki, Chen, Minshan, Cheng, Ann Lii, Cheng, Gregory, Chuang, Wan Long, Baatarkhuu, Oidov, Bi, Feng, Dan, Yock Young, Gani, Rino A., Tanaka, Atsushi, Jafri, Wasim, Jia, Ji Dong, Kao, Jia Horng, Hasegawa, Kiyoshi, Lau, Patrick, Lee, Jeong Min, Liang, Jun, Liu, Zhenwen, Lu, Yinying, Pan, Hongming, Payawal, Diana A., Rahman, Salimur, Seong, Jinsil, Shen, Feng, Shiha, Gamal, Song, Tianqiang, Sun, Hui Chuan, Masaki, Tsutomu, Sirachainan, Ekaphop, Wei, Lai, Yang, Jin Mo, Sallano, Jose D., Zhang, Yanqiao, Tanwandee, Tawesak, Dokmeci, AKadir, Zheng, Shu Sen, fan, Jia, Fan, Sheung Tat, Sarin, Shiv Kumar, Omata, Masao. APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024[J]. Hepatology International, 2024, 18(6), 1661-1683.
Authors:  Lau, George;  Obi, Shuntaro;  Zhou, Jian;  Tateishi, Ryosuke;  Qin, Shukui; et al.
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:5.9/6.6 | Submit date：2024/12/05
Hepatocellular Carcinoma  Systemic Therapy  Guidelines  The Asian Pacific Association For The Study Of The Liver  
Noncanonical Regulation of HOIL-1 on Cancer Stemness and Sorafenib Resistance Identifies Pixantrone as A Novel Therapeutic Agent for Hepatocellular Carcinoma Journal article
Chen, Peng, Dong, Zheyu, Zhu, Wei, Chen, Junling, Zhou, Yuxin, Ye, Qiuyue, Liao, Xinxin, Tan, Yongfa, Li, Chuanjiang, Wang, Yuhao, Pang, Huajin, Wen, Chunhua, Jiang, Yuchuan, Li, Xiaoqing, Li, Bo, Aimaier, Aihetaimu, Lin, Li, Sun, Jian, Hou, Jiajie, Tang, Libo, Hou, Jinlin, Li, Yongyin. Noncanonical Regulation of HOIL-1 on Cancer Stemness and Sorafenib Resistance Identifies Pixantrone as A Novel Therapeutic Agent for Hepatocellular Carcinoma[J]. Hepatology, 2024.
Authors:  Chen, Peng;  Dong, Zheyu;  Zhu, Wei;  Chen, Junling;  Zhou, Yuxin; et al.
Favorite |   IF:12.9/15.5 | Submit date：2023/08/31
Noncanonical regulation of HOIL-1 on cancer stemness and sorafenib resistance identifies pixantrone as a novel therapeutic agent for HCC Journal article
Chen, Peng, Dong, Zheyu, Zhu, Wei, Chen, Junling, Zhou, Yuxin, Ye, Qiuyue, Liao, Xinxin, Tan, Yongfa, Li, Chuanjiang, Wang, Yuhao, Pang, Huajin, Wen, Chunhua, Jiang, Yuchuan, Li, Xiaoqing, Li, Bo, Aimaier, Aihetaimu, Lin, Li, Sun, Jian, Hou, Jiajie, Tang, Libo, Hou, Jinlin, Li, Yongyin. Noncanonical regulation of HOIL-1 on cancer stemness and sorafenib resistance identifies pixantrone as a novel therapeutic agent for HCC[J]. Hepatology, 2024, 80(2), 330-345.
Authors:  Chen, Peng;  Dong, Zheyu;  Zhu, Wei;  Chen, Junling;  Zhou, Yuxin; et al.
Favorite | TC[WOS]:3 TC[Scopus]:2  IF:12.9/15.5 | Submit date：2024/08/05
Molecular force-induced liberation of transforming growth factor-beta remodels the spleen for ectopic liver regeneration Journal article
Wang Zhenzhen, Xie Daping, Li Jiayi, Zhai Ziyu, Lu Zhoujian, Tian Xuejiao, Liu Yiming, Zhao Qi, Zheng Peng, Dong Lei, Wang Chunming. Molecular force-induced liberation of transforming growth factor-beta remodels the spleen for ectopic liver regeneration[J]. Journal of Hepatology, 2024, 80(5), 753-763.
Authors:  Wang Zhenzhen;  Xie Daping;  Li Jiayi;  Zhai Ziyu;  Lu Zhoujian; et al.
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:26.8/28.0 | Submit date：2024/01/25
Transforming Growth Factor-β  Glycosaminoglycans  Biomaterials  Liver Regeneration  Tissue Remodelling  Hyaluronic Acid  
Clinical research advances in chimeric antigen receptor T - cell therapy for primary liver cancer 嵌合抗原受体 T 细胞治疗原发性肝癌临床研究进展 Journal article
Li,Shuang, Liu,Zherui, Lu,Yinying. Clinical research advances in chimeric antigen receptor T - cell therapy for primary liver cancer 嵌合抗原受体 T 细胞治疗原发性肝癌临床研究进展[J]. Journal of Clinical Hepatology, 2023, 39(5), 1019-1029.
Authors:  Li,Shuang;  Liu,Zherui;  Lu,Yinying
Favorite | TC[Scopus]:0 | Submit date：2023/08/03
Carcinoma, Hepatocellular  Chimeric Antigen  Receptors  T-lymphocytes  Therapeutics  
Clinical research advances in chimeric antigen receptor T-cell therapy for primary liver cancer Journal article
Li, Shuang, Liu, Zherui, Zhao, Qi, Lu,Yinying. Clinical research advances in chimeric antigen receptor T-cell therapy for primary liver cancer[J]. Journal of Clinical Hepatology, 2023, 39(5), 1019-1029.
Authors:  Li, Shuang;  Liu, Zherui;  Zhao, Qi;  Lu,Yinying
Favorite | TC[Scopus]:0 | Submit date：2023/08/28
Src homology 3 domain binding kinase 1 protects against hepatic steatosis and insulin resistance through the Nur77–FGF21 pathway Journal article
Ahuja, Palak, Bi, Xinyi, Ng, Chun Fai, Tse, Margaret Chui Ling, Hang, Miaojia, Pang, Brian Pak Shing, Iu, Elsie Chit Yu, Chan, Wing Suen, Ooi, Xin Ci, Sun, Anqi, Herlea-Pana, Oana, Liu, Zhixue, Yang, Xiuying, Jiao, Baowei, Ma, Xin, Wu, Kelvin Ka Lok, Lee, Leo Tsz On, Cheng, Kenneth King Yip, Lee, Chi Wai, Chan, Chi Bun. Src homology 3 domain binding kinase 1 protects against hepatic steatosis and insulin resistance through the Nur77–FGF21 pathway[J]. Hepatology, 2023, 77(1), 213-229.
Authors:  Ahuja, Palak;  Bi, Xinyi;  Ng, Chun Fai;  Tse, Margaret Chui Ling;  Hang, Miaojia; et al.
Favorite | TC[WOS]:11 TC[Scopus]:11  IF:12.9/15.5 | Submit date：2022/05/17
Growth-factor 21  Orphan Nuclear Receptors  Transcriptional Regulators  Metabolic-activity  Beta-klotho  Expression  Fgf21  Phosphorylation  Activation  Obesity  
N-terminal propeptide of type 3 collagen-based sequential algorithm can identify high-risk steatohepatitis and fibrosis in MAFLD Journal article
Liang‑Jie Tang, Gang Li, Mohammed Eslam, Pei‑Wu Zhu, Sui‑Dan Chen, Howard Ho‑Wai Leung, Ou‑Yang Huang, Grace Lai‑Hung Wong, Yu‑Jie Zhou, Morten Karsdal, Diana Julie Leeming, Pei Jiang, Cong Wang, Hai‑Yang Yuan, Christopher D. Byrne, Giovanni Targher, Jacob George, Vincent Wai‑Sun Wong, Ming‑Hua Zheng. N-terminal propeptide of type 3 collagen-based sequential algorithm can identify high-risk steatohepatitis and fibrosis in MAFLD[J]. Hepatology International, 2022, 17, 190–201.
Authors:  Liang‑Jie Tang;  Gang Li;  Mohammed Eslam;  Pei‑Wu Zhu;  Sui‑Dan Chen; et al.
Favorite | TC[WOS]:10 TC[Scopus]:9  IF:5.9/6.6 | Submit date：2023/01/30
Metabolic Dysfunction-associated Fatty Liver Disease  Steatohepatitis  Sequential Algorithm  Fibrosis Staging  
Evaluation of Preoperative Microvascular Invasion in Hepatocellular Carcinoma Through Multidimensional Parameter Combination Modeling Based on Gd-EOB-DTPA MRI Journal article
Zhang, Han Dan, Li, Xiao Ming, Zhang, Yu Han, Hu, Fang, Tan, Liang, Wang, Fang, Jing, Yang, Guo, Da Jing, Xu, Yang, Hu, Xian Ling, Liu, Chen, Wang, Jian. Evaluation of Preoperative Microvascular Invasion in Hepatocellular Carcinoma Through Multidimensional Parameter Combination Modeling Based on Gd-EOB-DTPA MRI[J]. Journal of Clinical and Translational Hepatology, 2022, 11(2), 350-359.
Authors:  Zhang, Han Dan;  Li, Xiao Ming;  Zhang, Yu Han;  Hu, Fang;  Tan, Liang; et al.
Favorite | TC[WOS]:7 TC[Scopus]:8  IF:3.1/3.7 | Submit date：2023/02/28
Hepatocellular Carcinoma  Microvascular Invasion  Radiomics  Gd-eob-dtpa  
Preoperative Assessment of Abdominal Adipose Tissue to Predict Microvascular Invasion in Small Hepatocellular Carcinoma Journal article
Wu, Zongqian, Lu, Hong, Xie, Qiao, Cheng, Jie, Ma, Kuansheng, Hu, Xiaofei, Tan, Liang, Zhang, Huarong, Liu, Chen, Li, Xiaoming, Cai, Ping. Preoperative Assessment of Abdominal Adipose Tissue to Predict Microvascular Invasion in Small Hepatocellular Carcinoma[J]. Journal of Clinical and Translational Hepatology, 2022, 10(2), 184-189.
Authors:  Wu, Zongqian;  Lu, Hong;  Xie, Qiao;  Cheng, Jie;  Ma, Kuansheng; et al.
Favorite | TC[WOS]:3 TC[Scopus]:4  IF:3.1/3.7 | Submit date：2022/05/17
Computed Tomography  Hepatocellular Carcinoma  Subcutaneous Adipose Tissue  Visceral Adipose Tissue